South African Psychiatry - November 2018
South African Psychiatry - November 2018
South African Psychiatry - November 2018
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
ADHD should not be a barrier<br />
to realising my potential<br />
I can t<br />
focus<br />
I procrastinate<br />
I feel<br />
different<br />
Emotional<br />
I STRUGGLE<br />
TO REMEMBER<br />
THINGS<br />
I CAN’T<br />
SIT STILL IN<br />
MEETINGS<br />
Time management<br />
is a challenge<br />
for me<br />
Unlocking potential<br />
FIRST GENERIC<br />
methylphenidate ER<br />
TO MAR KET<br />
S6 CONTRAMYL XR 18 mg (Extended Release Tablets). Reg. No. 49/1.2/1137. Each extended release tablet contains 18 mg<br />
methylphenidate hydrochloride. Contains sugar (sucrose). S6 CONTRAMYL XR 27 mg (Extended Release Tablets). Reg. No. 49/1.2/1138.<br />
Each extended release tablet contains 27 mg methylphenidate hydrochloride. Contains sugar (sucrose). S6 CONTRAMYL XR 36 mg<br />
(Extended Release Tablets). Reg. No. 49/1.2/1139. Each extended release tablet contains 36 mg methylphenidate hydrochloride. Contains<br />
sugar (sucrose). S6 CONTRAMYL XR 54 mg (Extended Release Tablets). Reg. No. 49/1.2/1140. Each extended release tablet contains<br />
54 mg methylphenidate hydrochloride. Contains sugar (sucrose).<br />
For full prescribing information refer to the package insert approved by the medicines regulatory authority.<br />
Mylan (Pty) Ltd. Reg. No.: 1949/035112/07. Building 6, Greenstone Hill Office Park, Emerald Boulevard, Modderfontein, 1645.<br />
Tel: (011) 451 1300. Fax: (011) 451 1400. www.mylansa.co.za<br />
M1617 Dec-17.